Mustafa Abdo
@respabdo
Followers
39
Following
328
Media
0
Statuses
39
MD | PhD| Pulmonologist | Principal Investigator at German Center for Lung Research & Airway Research Center North| 🇯🇴 🇩🇪
Joined January 2023
#WAOJournal: Exploring trends and predictors of long-term #asthma #remission. Open Access. https://t.co/gKtdxa9E3i
0
5
6
Oscillometry-defined Small Airway Dysfunction in Tobacco-exposed Adults with Impaired or Preserved Airflow Preserved airflow–small airway dysfunction: a pre-COPD phenotype diagnosed by oscillometry @respabdo @atscommunity 🔓 Open Access 🔗 https://t.co/zSORuZ3ZSL
0
7
19
In this editorial, the authors discuss the importance of establishing a robust case definition of “young COPD” and the consequences of such a diagnosis. 🫁 Full editorial: https://t.co/9pU6iGzlHP
#Pulmonology
1
1
4
A Stats, STAT! video explains how restricted mean survival time summarizes survival from time 0 to a fixed, pre-specified period of follow-up. Watch now: https://t.co/bNH15GwlSK
0
17
53
Carcinogenic Industrial Air Emissions and Lung Cancer Risk in a Cohort of 440,000 Americans @atscommunity 🔗 https://t.co/BYKsWQ29a4
0
1
2
Is Achieving a Fully Race-Neutral Approach to Lung Function Classification Even Possible? None of the commonly used spirometry outputs can simultaneously meet different definitions of race-neutrality @suryapbhatt
@atscommunity 🔓 Open Access 🔗 https://t.co/CoteOHnyFC
0
4
5
Echocardiographic Endophenotypes of Chronic Obstructive Pulmonary Disease: A Step toward Personalized Medicine @atscommunity 🔓 Open Access 🔗
0
1
11
Check out our latest @ATSBlueEditor publication: Beyond the well-known HFpEF in COPD, we identify a COPD-specific LV dysfunction phenotype linked to reduced venous return and increased all-cause mortality 👇🏻
Characterization and Mortality Risk of Impaired Left Ventricular Filling in COPD This analysis found that impaired left ventricular filling spikes all-cause mortality in COPD and uncovered two treatable traits @respabdo 🔓Open Access 🔗 https://t.co/OyHTPrN2yF
0
0
1
Hard to comprehend and even harder to accept: a 46.3%, or 35 year (!), loss of life expectancy in the Gaza Strip during the period October, 2023, to September, 2024. Touched by this @TheLancet paper. https://t.co/UnBXjTluWM
1
4
7
Glad to share exciting new findings from our recent study on IL-33 and its role in asthma and COPD, where we measured IL-33 levels in induced sputum using ultra-sensitive assay..
ERJ: In patients with COPD, targeting IL-33 might be auspicious in former smokers. However, disease severity should also be considered. In patients with severe asthma, targeting IL-33 might be a potential treatment option, irrespective of T2-status. https://t.co/jbF9faDc30
0
5
6
How to improve post-COVID muscular dysfunction? Check this Impressive work by @Transparent_AC & @bnrgm
The Blue Journal thanks Binaya Regmi, MD, for his contribution to the September 1 issue Improving Dyspnea after COVID-19 with Inspiratory Muscle Training @Transparent_AC
https://t.co/UHEo9NLvj8
0
0
3
Super fun co-chairing the @AstraZeneca EC global respiratory leadership forum alongside the #ERSCongress2024 in Vienna. Thank you everyone for making this a great success!
0
5
26
A landmark paper on protein aging clocks, validated across 3 country biobanks (UK, FInland, China) for association with risk of 18 chronic diseases, mortality, and age-related traits such as cognitive decline @NatureMedicine @austinargen and colleagues https://t.co/ClHrHTRWbC
7
146
492
Breathe: Imaging plays a vital role in asthma diagnosis and detection or exclusion of comorbidities. Further research is required to standardise the application of imaging in asthma and allied diseases. https://t.co/AD6dylCAHf
1
15
33
Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? Pre-bronchodilator FEV1/FVC at the 10th percentile identifies those at risk of developing COPD in community settings 🔗 https://t.co/ysZqTOdcIP
0
10
15
Special Article: Implications of Race Adjustment in Lung-Function Equations https://t.co/uQ83ohdbbd Editorial: Beyond Diagnostics — Removing Race from Lung-Function Test Interpretation https://t.co/DTrbUi2OeR
#ATS2024 @atscommunity
0
32
74
Presented at #ATS2024: In the NOTUS trial involving patients with COPD and type 2 inflammation shown by elevated blood eosinophil counts, treatment with dupilumab reduced disease exacerbation and improved lung function. Full trial results: https://t.co/NrXqtU4fUu
2
46
133
Presented at #ATS2024: UCAP trial: Case finding for symptomatic adults with undiagnosed asthma or COPD was coupled with a randomized trial to compare pulmonologist-directed and usual care. Pulmonologist-directed care led to less health care utilization. https://t.co/y8On3u8uw1
4
65
194
Early-Life Exposure to Air Pollution and Childhood Asthma Cumulative Incidence
jamanetwork.com
This cohort study examines the association of exposure to air pollution with asthma incidence in early and middle childhood and investigates whether individual and community-level characteristics...
0
5
12